Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. SBH
SBH logo

SBH Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Sally Beauty Holdings Inc (SBH) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
14.030
1 Day change
1.23%
52 Week Range
17.920
Analysis Updated At
2026/04/24
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Sally Beauty Holdings Inc (SBH) is not a strong buy at the moment for a beginner investor with a long-term focus. While the stock has some positive catalysts, including raised price targets and ongoing growth initiatives, the financial performance shows declining net income and EPS, which raises concerns about profitability. Additionally, technical indicators and options data do not suggest a strong bullish sentiment. Given the lack of significant positive signals from Intellectia Proprietary Trading Signals and no recent news or influential trading activity, it is better to hold off on buying this stock for now.

Technical Analysis

The MACD is positive but contracting, indicating a weakening bullish momentum. RSI is neutral at 53.677, and moving averages are converging, suggesting no clear trend. The stock is trading near its pivot level of 14.584, with resistance at 15.401 and support at 13.766. Overall, the technical indicators do not provide a strong buy signal.

Options Data

Bearish
Open Interest Put-Call Ratio
Bearish
Option Volume Put-Call Ratio

The high Open Interest Put-Call Ratio indicates a bearish sentiment among options traders, while the Option Volume Put-Call Ratio of 1.71 suggests a higher volume of puts compared to calls, further supporting a cautious outlook.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
6
Buy
4

Positive Catalysts

  • Analysts have raised price targets, with TD Cowen and Canaccord maintaining Buy ratings. Growth-driving initiatives are in early stages, which could provide long-term benefits.

Neutral/Negative Catalysts

  • Net income and EPS have significantly declined YoY, indicating profitability challenges. Morgan Stanley maintains an Underweight rating, citing limited medium-term EBIT growth. Options data reflects bearish sentiment, and there are no recent news or influential trading activities to drive the stock upward.

Financial Performance

In Q1 2026, revenue increased slightly by 0.56% YoY, but net income dropped by -25.33%, and EPS fell by -22.41%. Gross margin improved marginally by 0.79% YoY to 51.24%. Overall, the financial performance is mixed, with declining profitability being a key concern.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts have raised price targets, with TD Cowen and Canaccord setting targets at $20 and maintaining Buy ratings. However, Morgan Stanley raised its target to $16 but kept an Underweight rating, citing limited medium-term EBIT growth.

Wall Street analysts forecast SBH stock price to rise
4 Analyst Rating
Wall Street analysts forecast SBH stock price to rise
2 Buy
1 Hold
1 Sell
Hold
Current: 13.860
sliders
Low
13
Averages
15.88
High
19
Current: 13.860
sliders
Low
13
Averages
15.88
High
19
TD Cowen
Buy
maintain
$18 -> $20
AI Analysis
2026-02-10
Reason
TD Cowen
Price Target
$18 -> $20
AI Analysis
2026-02-10
maintain
Buy
Reason
TD Cowen raised the firm's price target on Sally Beauty to $20 from $18 and keeps a Buy rating on the shares. The firm updated its model following Q1 results where durable margins drove upside.
Morgan Stanley
Simeon Gutman
Underweight
maintain
$14 -> $16
2026-02-10
Reason
Morgan Stanley
Simeon Gutman
Price Target
$14 -> $16
2026-02-10
maintain
Underweight
Reason
Morgan Stanley analyst Simeon Gutman raised the firm's price target on Sally Beauty to $16 from $14 and keeps an Underweight rating on the shares. While benefits from strategic initiatives should continue throughout FY26, medium-term EBIT growth is likely limited as cost savings wind down and expenses normalize, the analyst tells investors in a post-earnings note.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for SBH
Unlock Now

People Also Watch